News
May 2019
Cancer Vaccines Development: Supported by CIBR CORE Services
The University of Maryland School of Medicine’s (UMSOM) Center for Innovative Biomedical Resources (CIBR) serves as a center of excellence for state-of-the-art technologies, high-tech instrumentation, and expertise that supports biomedical research, clinical practice, and health care in the state of Maryland and the region. This regular feature of SOMNews highlights UMSOM faculty who are seeing significant results from using CIBR Cores.
January 2019
2019 CIBR Travel Awards
The Center for Innovative Biomedical Resources (CIBR) is pleased to announce the recipients of its 2019 Travel Awards. Ying Zou, MD, PhD, Director of the Cytogenetics Laboratory and Director of the Translational Genomics Laboratory and Brandon Carter-Cooper, Research Lead Specialist of the Translational Laboratory Shared Service were selected by committee from a pool of applicants.
May 2018
Voucher Program News UMB ICTR Director Introduces the ICTR
Congratulations to the recipients of the ICTR Voucher Program Inaugural Round! Watch a video featuring Dr. Stephen Davis, UMB ICTR Director, introduceing the UMB Institute for Clinical & Translational Research (ICTR).
January 2018
2018 CIBR Travel Awards
The Center for Innovative Biomedical Resources (CIBR) is pleased to announce the recipients of its 2018 Travel Awards. Regina Harley, Lab Supervisor of the Center for Vaccine Development’s Flow & Mass Cytometry Core and Ashley Cellini, Manager of the University of Maryland Greenebaum Comprehensive Cancer Center’s Pathology Biorepository Core were selected by committee from a pool of applications and will each receive a $2,000.00 travel award to offset the cost of attending the Association of Biomolecular Resource Facilities (ABRF) annual meeting. This annual international meeting is the premier conference for Core Facility directors, staff and administrators.
More News...
UMB ICTR Sponsoring “Micro Grants” for Use of CIBR’s & other UMB Core Facilities/Services
UMMC Offers Genetic Testing as Standard of Care to Help Improve Outcomes for Heart Stent Patients